Rak piersi
Diagnostyka i diagnoza
Rak piersi (carcinoma mammae) jest jednym z najczęściej diagnozowanych nowotworów złośliwych u kobiet, stanowiąc główną przyczynę zachorowań w Polsce. Diagnostyka opiera się na wieloetapowym podejściu, obejmującym badanie kliniczne, obrazowe (mammografia, USG, MRI), biopsję oraz badania laboratoryjne i molekularne. Mammografia, wykonywana co 1-2 lata u kobiet po 50. roku życia, pozostaje podstawową metodą przesiewową, umożliwiającą wykrycie zmian niewyczuwalnych palpacyjnie. USG jest szczególnie przydatne u kobiet z gęstą tkanką gruczołową oraz jako badanie uzupełniające. MRI, bardziej czułe niż mammografia i USG, stosuje się u pacjentek z wysokim ryzykiem (np. nosicielki mutacji BRCA1/BRCA2) oraz do oceny rozległości choroby i odpowiedzi na leczenie. Biopsja, w tym cienko- i gruboigłowa oraz biopsja węzła wartowniczego (SLNB), jest niezbędna do potwierdzenia diagnozy i oceny charakterystyki nowotworu.
Diagnostyka Raka Piersi
Rak piersi (łac. carcinoma mammae) jest jednym z najczęściej diagnozowanych nowotworów u kobiet na całym świecie. W Polsce stanowi on również główną przyczynę zachorowań na nowotwory złośliwe wśród kobiet. Wczesne wykrycie i prawidłowa diagnostyka raka piersi są kluczowe dla skutecznego leczenia i zwiększenia szans na przeżycie. Diagnostyka raka piersi opiera się na kompleksowym podejściu obejmującym badania obrazowe, biopsję oraz badania laboratoryjne.12
Badanie kliniczne
Pierwszym etapem diagnostyki raka piersi jest dokładne badanie kliniczne. Lekarz przeprowadza wywiad medyczny, zbiera informacje o objawach, czynnikach ryzyka oraz historii chorób w rodzinie. Następnie wykonuje badanie fizykalne piersi i węzłów chłonnych w dole pachowym. Badanie to pozwala na wstępną ocenę zmian wyczuwalnych w piersi, takich jak guzki, zgrubienia, asymetria piersi czy zmiany skórne. Warto podkreślić, że sam wynik badania klinicznego nie jest wystarczający do postawienia diagnozy raka piersi – konieczne są dalsze badania diagnostyczne.34
Diagnostyka obrazowa
Mammografia
Mammografia jest podstawowym badaniem obrazowym stosowanym w diagnostyce raka piersi. Polega na wykonaniu zdjęcia rentgenowskiego tkanki piersiowej przy użyciu niskiej dawki promieniowania. Mammografia umożliwia wykrycie zmian w piersi, które mogą być niewyczuwalne podczas badania palpacyjnego. Jest to szczególnie istotne, ponieważ rak piersi we wczesnym stadium zwykle nie daje objawów.56
Wyróżniamy dwa typy mammografii:
- Mammografia przesiewowa – wykonywana u kobiet bez objawów w ramach badań profilaktycznych
- Mammografia diagnostyczna – bardziej szczegółowa, wykonywana w przypadku wykrycia nieprawidłowości podczas badania przesiewowego lub występowania objawów klinicznych (np. wyczuwalnego guzka, bólu piersi, wycieku z brodawki)
Mammografia jest obecnie najskuteczniejszą metodą wczesnego wykrywania raka piersi, co znacząco zwiększa szanse na wyleczenie. Według zaleceń, kobiety po 50. roku życia powinny wykonywać mammografię co 1-2 lata. Dla kobiet w wieku 40-49 lat zalecenia różnią się w zależności od przyjętych wytycznych i indywidualnych czynników ryzyka.910
Ultrasonografia piersi
Ultrasonografia piersi (USG) wykorzystuje fale dźwiękowe do tworzenia obrazu tkanek piersi. Jest to badanie bezbolesne i bezpieczne, niewymagające użycia promieniowania. USG piersi jest szczególnie przydatne w różnicowaniu zmian torbielowatych (płynowych) od litych oraz w ocenie zmian u młodszych kobiet, które mają gęstą tkankę gruczołową piersi. W takich przypadkach mammografia może być mniej skuteczna ze względu na mniejszy kontrast między guzem a otaczającą tkanką.1112
USG jest często stosowane jako badanie uzupełniające mammografię, zwłaszcza gdy:
- Kobieta ma gęstą tkankę piersiową
- Mammografia wykazała podejrzane zmiany wymagające dalszej oceny
- Występuje wyczuwalny guzek, który nie jest widoczny w mammografii
- Pacjentka jest w ciąży lub karmi piersią
- Pacjentka ma mniej niż 30 lat
Rezonans magnetyczny piersi (MRI)
Rezonans magnetyczny piersi (MRI) jest zaawansowaną metodą obrazowania, która wykorzystuje pole magnetyczne i fale radiowe do tworzenia szczegółowych obrazów tkanek piersi. Badanie MRI jest bardziej czułe niż mammografia i ultrasonografia w wykrywaniu niektórych typów raka piersi, zwłaszcza u kobiet z wysokim ryzykiem zachorowania.1516
MRI piersi nie jest rutynowym badaniem przesiewowym, ale jest zalecane w następujących przypadkach:
- U kobiet z wysokim ryzykiem raka piersi (np. nosicielek mutacji genów BRCA1/BRCA2)
- Do oceny rozległości nowotworu po diagnozie
- Do oceny odpowiedzi na leczenie neoadjuwantowe
- Do wykrywania nawrotu choroby
- Gdy wyniki mammografii i USG są niejednoznaczne
- Do badania kobiet z implantami piersiowymi
Dynamiczne badanie MRI z kontrastem polega na analizie wzorca wzmocnienia tkanki po dożylnym podaniu środka kontrastowego. Ta nieinwazyjna technika umożliwia ilościowe określenie stopnia unaczynienia tkanki, składu przestrzeni międzykomórkowej i różnicowania zmian, co jest kluczowe w diagnostyce raka piersi.19
Inne badania obrazowe
W diagnostyce raka piersi wykorzystuje się również inne metody obrazowania, choć są one stosowane rzadziej:
- Badanie scyntymamograficzne (BSGI) – technika obrazowania molekularnego piersi, która pozwala na wykrycie submilimetrowych i mammograficznie niewidocznych raków piersi z czułością i swoistością porównywalną do MRI20
- Duktografia – specjalny rodzaj zdjęcia rentgenowskiego, który bada przewody mleczne piersi. Jest czasem stosowany do ustalenia przyczyny wydzieliny z brodawki sutkowej21
- Tomosynteza mammograficzna – metoda tworzenia trójwymiarowego obrazu piersi za pomocą przekrojów rentgenowskich, co zwiększa wykrywalność raka u pacjentek bez objawów22
Biopsja piersi
Biopsja jest kluczowym badaniem w diagnostyce raka piersi i jedynym sposobem na jednoznaczne potwierdzenie obecności komórek nowotworowych. Polega na pobraniu próbki tkanki lub płynu z podejrzanego obszaru piersi do badania mikroskopowego. Wynik biopsji pozwala na postawienie ostatecznej diagnozy oraz określenie typu i charakterystyki nowotworu.2324
Istnieje kilka rodzajów biopsji piersi:
- Biopsja cienkoigłowa (FNA) – polega na pobraniu komórek za pomocą cienkiej igły do badania cytologicznego. Stosowana głównie do oceny torbieli lub guzków wyczuwalnych w badaniu25
- Biopsja gruboigłowa – wykorzystuje grubszą igłę do pobrania fragmentu tkanki, co umożliwia ocenę struktury guza. Jest bardziej dokładna niż biopsja cienkoigłowa i stanowi standardową metodę diagnostyczną26
- Biopsja mammotomiczna (wspomagana próżnią) – pozwala na pobranie większych próbek tkanki za pomocą specjalnego urządzenia27
- Biopsja chirurgiczna (otwarta) – polega na chirurgicznym usunięciu całej zmiany lub jej części w celu dokładnego zbadania28
Biopsje mogą być wykonywane pod kontrolą różnych metod obrazowania:
- Pod kontrolą USG (najczęściej)
- Pod kontrolą mammografii (stereotaktyczna)
- Pod kontrolą MRI
Biopsja węzłów wartowniczych
Biopsja węzła wartowniczego (SLNB) to rewolucyjna, minimalnie inwazyjna metoda stosowana do określenia, czy przerzuty wystąpiły u pacjentek z rakiem piersi we wczesnym stadium. Polega na zidentyfikowaniu i pobraniu próbki z węzłów chłonnych, które jako pierwsze odbierają chłonkę z okolic guza piersi. Jeśli w węźle wartowniczym nie zostanie znaleziony nowotwór, dodatkowe węzły chłonne nie muszą być usuwane, co zmniejsza ryzyko obrzęku limfatycznego (limfedemy) ramienia.3132
Badania laboratoryjne i molekularne
Po potwierdzeniu diagnozy raka piersi wykonuje się szereg badań laboratoryjnych i molekularnych, które pomagają określić charakterystykę nowotworu i zaplanować najskuteczniejsze leczenie:3334
Oznaczanie receptorów hormonalnych
Badanie statusu receptorów hormonalnych polega na sprawdzeniu obecności receptorów estrogenowych (ER) i progesteronowych (PR) w komórkach raka piersi. Nowotwory, które posiadają te receptory (ER+/PR+), są zależne od hormonów i mogą reagować na terapię hormonalną. Około 70% raków piersi wykazuje obecność receptorów hormonalnych.3536
Oznaczanie statusu HER2
Badanie statusu HER2 (receptor ludzkiego naskórkowego czynnika wzrostu 2) polega na sprawdzeniu, czy komórki raka produkują zbyt dużo białka HER2. Nadekspresja HER2 występuje w około 15-20% przypadków raka piersi i jest związana z bardziej agresywnym przebiegiem choroby, ale też z możliwością zastosowania terapii celowanej anty-HER2.3738
Raki piersi, które nie wykazują ekspresji receptorów estrogenowych, progesteronowych ani HER2, są określane jako potrójnie ujemne (triple-negative). Stanowią one około 10-15% wszystkich przypadków raka piersi i są zwykle bardziej agresywne, z mniejszą liczbą opcji terapeutycznych.3940
Badania genetyczne i genomowe
Badania genetyczne i genomowe odgrywają coraz większą rolę w diagnostyce i planowaniu leczenia raka piersi:
- Profilowanie molekularne – badania takie jak Oncotype DX (test 21-genowy) pozwalają określić ryzyko nawrotu choroby i potencjalne korzyści z chemioterapii u pacjentek z wczesnym stadium raka piersi41
- Badanie mutacji genetycznych – identyfikacja mutacji w genach takich jak BRCA1, BRCA2 i innych, które zwiększają ryzyko rozwoju raka piersi42
- Badanie indeksu proliferacji Ki-67 – marker proliferacji komórkowej, który pomaga określić szybkość wzrostu komórek nowotworowych43
Badania dodatkowe w ocenie zaawansowania choroby
Po zdiagnozowaniu raka piersi, wykonuje się dodatkowe badania w celu określenia stopnia zaawansowania choroby (staging) i wykluczenia obecności przerzutów odległych:4445
- Badania krwi – morfologia, badania biochemiczne oceniające funkcję wątroby i nerek, markery nowotworowe
- RTG klatki piersiowej – do wykluczenia przerzutów do płuc
- Scyntygrafia kości – w przypadku podejrzenia przerzutów do kości
- Tomografia komputerowa (CT) – do oceny narządów wewnętrznych
- Pozytonowa tomografia emisyjna (PET) – pozwala na wykrycie ognisk raka w całym organizmie
Określenie stadium zaawansowania raka piersi
Na podstawie wyników wszystkich badań określa się stadium zaawansowania raka piersi według klasyfikacji TNM, która uwzględnia:4849
- T (tumor) – wielkość guza pierwotnego
- N (nodes) – obecność przerzutów do węzłów chłonnych
- M (metastasis) – obecność przerzutów odległych
Wyróżnia się 5 głównych stadiów raka piersi:
- Stadium 0 (przedinwazyjny/in situ) – rak jest ograniczony do przewodów lub zrazików piersi i nie naciekał tkanki piersiowej
- Stadium I – wczesny inwazyjny rak piersi; guz nie większy niż 2 cm, bez zajęcia węzłów chłonnych
- Stadium II – guz o wielkości 2-5 cm i/lub z przerzutami do węzłów chłonnych pachowych
- Stadium III – miejscowo zaawansowany rak piersi; guz może być większy niż 5 cm i/lub szeroko rozprzestrzenia się w tkance piersiowej czy węzłach chłonnych
- Stadium IV (przerzutowy) – rak rozprzestrzenił się do odległych narządów, takich jak płuca, wątroba, kości czy mózg
Stopień zaawansowania nowotworu jest kluczowy dla określenia rokowania i wyboru odpowiedniej strategii leczenia. Im niższe stadium, tym lepsze rokowanie i większe szanse na całkowite wyleczenie. Pięcioletnie przeżycie w przypadku raka piersi wykrytego we wczesnym stadium (zlokalizowanym, ograniczonym do piersi) wynosi około 99%.5253
Nowoczesne podejścia w diagnostyce
Sztuczna inteligencja w diagnostyce raka piersi
Sztuczna inteligencja (AI) staje się coraz ważniejszym narzędziem w diagnostyce raka piersi. Algorytmy AI mogą zwiększyć efektywność pracy radiologów i dostarczyć ilościowych analiz, które nie podlegają ludzkiemu błędowi, podejmując decyzje na podstawie danych dla wątpliwych mammogramów, które mogłyby być różnie interpretowane.5455
Techniki AI mogą pomóc radiologom w identyfikacji raka piersi, który w przeciwnym razie byłby niewykrywalny we wczesnych stadiach. AI może również poprawić opiekę nad pacjentkami z rakiem piersi w obszarach o niskich zasobach lub na terenach wiejskich, gdzie kobiety często nie mają łatwego dostępu do specjalistów i ekspertów.5657
Biopsja płynna
Biopsja płynna to innowacyjne podejście diagnostyczne, które polega na wykrywaniu biomarkerów nowotworowych, takich jak krążące komórki nowotworowe (CTC) czy krążący DNA nowotworowy (ctDNA) we krwi. Metoda ta może uzupełniać tradycyjne techniki diagnostyczne, umożliwiając mniej inwazyjne monitorowanie postępów choroby i odpowiedzi na leczenie.58
Znaczenie wczesnego wykrywania
Wczesne wykrycie raka piersi jest kluczowe dla skutecznego leczenia i poprawy rokowania. Regularne badania przesiewowe, w tym mammografia, mogą wykryć raka na wczesnych etapach, zanim pojawią się objawy kliniczne. Badania pokazują, że kobiety, u których rak piersi został wykryty we wczesnym stadium, mają znacznie lepsze rokowanie i mogą wymagać mniej intensywnego leczenia.5960
Około 66% przypadków raka piersi jest diagnozowanych w stadium lokalnym, przed rozprzestrzenieniem się poza pierś, gdy leczenie jest najłatwiejsze. Pięcioletni wskaźnik przeżycia dla raka diagnozowanego w stadium lokalnym wynosi 99%. Kobiety, które regularnie wykonują badania przesiewowe w kierunku raka piersi, mają o 26% niższy wskaźnik śmiertelności z powodu raka piersi niż kobiety, które nie wykonują badań przesiewowych.61
Podsumowanie
Diagnostyka raka piersi jest procesem wieloetapowym, który obejmuje badanie kliniczne, badania obrazowe (mammografia, USG, MRI), biopsję oraz badania laboratoryjne i molekularne. Każdy z tych etapów dostarcza cennych informacji, które razem pozwalają na postawienie precyzyjnej diagnozy, określenie stopnia zaawansowania choroby i zaplanowanie optymalnego leczenia.
Dzięki postępowi w dziedzinie diagnostyki obrazowej, biologii molekularnej i genetyki, diagnostyka raka piersi staje się coraz bardziej precyzyjna, umożliwiając indywidualizację postępowania terapeutycznego. Kluczowe znaczenie ma jednak wczesne wykrycie choroby, dlatego tak ważne są regularne badania przesiewowe u kobiet z grupy ryzyka oraz edukacja w zakresie samobadania piersi i rozpoznawania niepokojących objawów.
Kolejne rozdziały
Zapraszamy do dalszego czytania naszego leksykonu.
Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.
Materiały źródłowe
- #1 Breast cancer – Diagnosis and treatment – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/breast-cancer/diagnosis-treatment/drc-20352475
Woman undergoing mammography exam Receiving a mammogram […] Breast cancer diagnosis often begins with an exam and a discussion of your symptoms. Imaging tests can look at the breast tissue for anything that’s not typical. To confirm whether there is cancer or not, a sample of tissue is removed from the breast for testing. […] A mammogram is an X-ray of the breast tissue. Mammograms are commonly used to screen for breast cancer. If a screening mammogram finds something concerning, you might have another mammogram to look at the area more closely. This more-detailed mammogram is called a diagnostic mammogram. It’s often used to look closely at both breasts. […] A breast MRI can make more-detailed pictures of the breast. Sometimes this method is used to look closely for any other areas of cancer in the affected breast. It also might be used to look for cancer in the other breast.
- #2 Current State of Breast Cancer Diagnosis, Treatment, and Theranosticshttps://pmc.ncbi.nlm.nih.gov/articles/PMC8156889/
Breast cancer is one of the leading causes of cancer-related morbidity and mortality in women worldwide. Early diagnosis and effective treatment of all types of cancers are crucial for a positive prognosis. Patients with small tumor sizes at the time of their diagnosis have a significantly higher survival rate and a significantly reduced probability of the cancer being fatal. Therefore, many novel technologies are being developed for early detection of primary tumors, as well as distant metastases and recurrent disease, for effective breast cancer management. […] Early diagnosis of the disease is crucial for effective treatment and positive prognosis, as significantly lower probability of dying and higher survival rate is observed in patients with smaller tumors at the time of diagnosis. Early detection of breast cancer and accurate lesion assessment are, therefore, the primary focus of all imaging modalities. At present the two major pillars to be addressed for effective management of breast cancer disease include: (i) diagnosis of breast cancer in its earliest stages and (ii) providing timely treatment after diagnosis to save lives.
- #3 Breast Cancer: Symptoms, Types, Causes & Treatmenthttps://my.clevelandclinic.org/health/diseases/3986-breast-cancer
Breast cancer is one of the most common cancers that affects women. It happens when cancerous cells in your breasts multiply and become tumors. About 80% of breast cancer cases are invasive, meaning a tumor may spread from your breast to other areas of your body. […] Healthcare providers may do physical examinations or order mammograms to check for signs of breast cancer. But they do the following tests to diagnose the disease: Breast ultrasound, Breast magnetic resonance imaging (MRI) scan, Breast biopsy, Immunohistochemistry test to check for hormone receptors, Genetic tests to identify mutations that cause breast cancer. […] Healthcare providers use cancer staging systems to plan treatment. Staging cancer also helps providers set a prognosis, or what you can expect after treatment. Breast cancer staging depends on factors like breast cancer type, tumor size and location, and whether cancer has spread to other areas of your body. Breast cancer stages are: Stage 0: The disease is noninvasive, meaning it hasnt spread from your breast ducts to other parts of your breast. Stage I: There are cancerous cells in nearby breast tissue. Stage II: The cancerous cells have formed a tumor or tumors. The tumor is either smaller than 2 centimeters across and has spread to underarm lymph nodes or larger than 5 centimeters across but hasnt spread to underarm lymph nodes. Tumors at this stage can measure anywhere between 2 and 5 centimeters across, and may or may not affect the nearby lymph nodes. Stage III: Theres breast cancer in nearby tissue and lymph nodes. Stage III is usually referred to as locally advanced breast cancer. Stage IV: Cancer has spread from your breast to areas like your bones, liver, lungs or brain. […] The most significant complication is metastatic breast cancer breast cancer that spreads to other areas of your body, including your brain, bones, liver and lungs. Studies show about 1 in 3 women who have early-stage cancer later develop metastatic breast cancer.
- #4 Tests for breast cancer | Cancer Research UKhttps://www.cancerresearchuk.org/about-cancer/breast-cancer/getting-diagnosed/tests
You usually have a number of tests to check for breast cancer. These include: a breast examination, mammogram, taking a sample of tissue from your breast called a biopsy, scans. […] Your GP might also ask about your family history. If you have a strong family history of cancer, there might be a faulty gene in your family that increases your risk of breast cancer. […] Some women do not have any symptoms and are referred to a breast clinic for tests if their screening mammogram shows an abnormal area. […] The tests you have can diagnose breast cancer and other breast conditions. […] A breast biopsy means taking samples of tissue from a suspicious area. It is the only way to find out if you have breast cancer or another breast condition. […] The tests can: diagnose breast cancer, show which type of breast cancer you have, look for proteins on the surface of the breast cancer cells.
- #5 Breast cancer – Diagnosis and treatment – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/breast-cancer/diagnosis-treatment/drc-20352475
Woman undergoing mammography exam Receiving a mammogram […] Breast cancer diagnosis often begins with an exam and a discussion of your symptoms. Imaging tests can look at the breast tissue for anything that’s not typical. To confirm whether there is cancer or not, a sample of tissue is removed from the breast for testing. […] A mammogram is an X-ray of the breast tissue. Mammograms are commonly used to screen for breast cancer. If a screening mammogram finds something concerning, you might have another mammogram to look at the area more closely. This more-detailed mammogram is called a diagnostic mammogram. It’s often used to look closely at both breasts. […] A breast MRI can make more-detailed pictures of the breast. Sometimes this method is used to look closely for any other areas of cancer in the affected breast. It also might be used to look for cancer in the other breast.
- #6 Diagnosing Breast Cancer | Breast Cancer | CDChttps://www.cdc.gov/breast-cancer/screening/diagnosis.html
If a screening mammogram is abnormal, doctors use more tests to find or diagnose breast cancer. […] If breast cancer is diagnosed, other tests are done to find out if cancer cells have spread within the breast or to other parts of the body. […] A breast cancer patient receiving an MRI Magnetic resonance imaging may be used to diagnose breast cancer. […] If a screening mammogram is abnormal, doctors use more tests to find out if it is breast cancer. […] These doctors are experts in diagnosing breast problems. […] If you have a problem in your breast, such as lumps, or if an area of the breast looks abnormal on a screening mammogram, doctors may have you get a diagnostic mammogram. This is a more detailed X-ray of the breast. […] Breast magnetic resonance imaging (MRI). A kind of body scan that uses a magnet linked to a computer. The MRI scan will make detailed pictures of areas inside the breast.
- #7 Breast Cancer Diagnosis and Screening | AAFPhttps://www.aafp.org/pubs/afp/issues/2000/0801/p596.html
Mammographic screening is appropriate for asymptomatic women. Diagnostic mammography, which may include additional views, is done for women with signs or symptoms of breast cancer. Any sign of cancer should be communicated to the radiologist with the referral for a diagnostic mammogram. […] The American Cancer Society (ACS) and the National Cancer Institute recommend screening mammograms every year for asymptomatic women 40 years and older. […] Regular screening mammography along with regular clinical breast examination offer the best opportunity to increase this percentage. […] Women between the ages of 40 and 69 have a 30 percent chance of a false-positive screening mammogram or breast examination over a 10-year period. […] It is extremely important to remember that 10 to 15 percent of all breast cancers are not detected by a mammogram. A careful clinical breast examination is also necessary. A palpable breast mass that is not seen on a mammogram should have a thorough diagnostic work-up including ultrasound and needle biopsy and close follow-up.
- #8 Detection & Diagnosis of Breast Cancer | WVCIhttps://www.oregoncancer.com/breast-cancer/detection-diagnosis
An important step women can take to protect their health is to get a mammogram. It is the American Cancer Society’s primary recommended breast cancer screening method. Because there are no symptoms of breast cancer at its earliest stages, this screening test saves lives. […] A mammogram is an X-ray picture of tissue inside the breast. It can often show a breast lump before it can be felt. They can also display a cluster of calcium specks called microcalcifications. Lumps or specks can be from cancer, precancerous cells, or other conditions. Further testing is needed to find out whether cancer cells are present. […] Women should get regular screening mammograms to detect breast cancer early even before they have symptoms. […] If the mammogram shows an abnormal area of the breast, your doctor may order more detailed images. Doctors use diagnostic mammograms to learn more about unusual breast changes, such as a lump, pain, thickening, nipple discharge, or change in breast size or shape. Diagnostic mammograms may focus on a specific area of the breast, offering more detailed views than traditional screening mammograms.
- #9 Breast Cancer Screening – NCIhttps://www.cancer.gov/types/breast/patient/breast-screening-pdq
Screening is looking for signs of disease, such as breast cancer, before a person has symptoms. The goal of screening tests is to find cancer at an early stage when it can be treated and may be cured. […] If a screening test result is abnormal, you may need to have more tests done to find out if you have cancer. These are called diagnostic tests, rather than screening tests. […] Mammography is the most common screening test for breast cancer. […] Mammography is an imaging test used to screen for and diagnose breast cancer. It can detect abnormal breast tissue, including cancer, sometimes before symptoms appear. […] Women aged 50 to 69 years who have screening mammograms have a lower chance of dying from breast cancer than women who do not have screening mammograms. […] MRI may be used as a screening test for women who have a high risk of breast cancer.
- #10 Recommendation: Breast Cancer: Screening | United States Preventive Services Taskforcehttps://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening
The Task Force now recommends that all women get screened every other year starting at age 40. This final recommendation also urgently calls for research in key areas. […] The Task Force recommends that all women get screened for breast cancer every other year, starting at age 40 and continuing through age 74, to reduce their risk of dying from this disease. This is a B grade. […] It is important to note that all women, including those with dense breasts, should be screened starting at age 40. […] Black women are 40 percent more likely to die from breast cancer than White women and too often get aggressive cancers at young ages. Ensuring Black women start screening at 40 is an important first step, yet it is not enough to improve these inequities. […] The USPSTF recommends biennial screening mammography for women aged 40 to 74 years.
- #11 Breast Cancer Diagnosis – National Breast Cancer Foundationhttps://www.nationalbreastcancer.org/breast-cancer-diagnosis/
Breast cancer can be diagnosed through multiple tests, including a mammogram, ultrasound, MRI, and biopsy. […] Regular screenings, including breast self-exams, mammograms, and clinical breast exams, can help detect cancer before signs or symptoms develop. […] A diagnostic mammogram is used if signs of breast cancer are present or after suspicious results are found on a screening mammogram. […] An ultrasound (or sonogram) may be used to help determine if a breast lump is a benign cyst or a solid mass that may indicate breast cancer. […] A breast MRI uses magnetic energy and radio waves to assess the size and specific location of an abnormal finding in the breast tissue. […] A biopsy removes tissue or fluid from a suspicious area in the breast tissue that is then examined to check for the presence of breast cancer. […] Lab tests, such as a hormone receptor test and HER2/neu test, are used to determine prognosis and treatment options after a breast cancer diagnosis. […] Waiting for the results of breast cancer screening or tests can be stressful, but there are ways to cope and help calm your mind and nerves.
- #12 Current State of Breast Cancer Diagnosis, Treatment, and Theranosticshttps://pmc.ncbi.nlm.nih.gov/articles/PMC8156889/
Breast specific gamma imaging (BSGI), a molecular breast imaging approach, is a specialized nuclear medicine imaging test that allows detection of sub-centimeter and mammographically occult breast cancer with a sensitivity and specificity comparable to MRI. […] Although mammography is a gold standard for breast cancer imaging, because of its limitations regarding dense breasts, another supplementing screening tool is required. Ultrasound is a supplemental tool that may be utilized to analyze some breast changes in women with dense breast tissues, as well as suspicious areas not seen on a mammogram. […] Breast cancer diagnosis by breast examination, mammography, breast ultrasound, MRI, and other imaging modalities can help identify tumors and other abnormalities in the tissue, as described above. These imaging modalities can help find a lump, an area of microcalcification, a suspicious area on ultrasound, or a gadolinium-enhanced area on MRI. Once breast cancer is identified using one of the diagnostic modalities discussed above, immediate and rigorous treatment must be provided to remove the tumor and prevent further spread of the cancer.
- #13 Breast Cancer Workup: Approach Considerations, Breast Cancer Screening, Ultrasonographyhttps://emedicine.medscape.com/article/1947145-workup
A number of screening modalities exist for breast cancer, including mammography, ultrasonography, and MRI. Breast self-examination is no longer recommended for screening. Instead, breast awareness is recommended; women should be familiar with how their breasts normally look and feel, and report any changes promptly to their health care provider. Most guidelines also recommend against clinical breast examination. […] Mammography is a low-dose x-ray-based modality used to image the breast. It is currently the best available population-based method for detecting breast cancer at an early stage. Mammography is used both for screening to detect a cancer and for diagnostic workup of patients after a tumor is detected. Screening mammography is performed in asymptomatic women, whereas diagnostic mammography is performed in symptomatic women (ie, when a breast lump or nipple discharge is present or when an abnormality is found during screening mammography).
- #14 Breast cancer (female) | NHS informhttps://www.nhsinform.scot/illnesses-and-conditions/cancer/cancer-types-in-adults/breast-cancer-female/
A biopsy is where a sample of tissue cells is taken from your breast and tested to see if it’s cancerous. You may also need a scan and a needle test on lymph nodes in your armpit (axilla) to see whether these are also affected. […] If you have symptoms and have been referred by your GP, you’ll meet a specialist who’ll examine you to determine if you need further tests. […] If you’re under 40 years of age, the specialist may suggest you only have a breast ultrasound scan. This is because younger women have denser breasts, which means a mammogram isn’t as effective as an ultrasound for diagnosing breast disease. […] If your cancer was detected through the NHS Breast Screening Programme, you’ll have further tests in the screening centre before being referred for treatment.
- #15 Breast cancer – Diagnosis and treatment – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/breast-cancer/diagnosis-treatment/drc-20352475
Woman undergoing mammography exam Receiving a mammogram […] Breast cancer diagnosis often begins with an exam and a discussion of your symptoms. Imaging tests can look at the breast tissue for anything that’s not typical. To confirm whether there is cancer or not, a sample of tissue is removed from the breast for testing. […] A mammogram is an X-ray of the breast tissue. Mammograms are commonly used to screen for breast cancer. If a screening mammogram finds something concerning, you might have another mammogram to look at the area more closely. This more-detailed mammogram is called a diagnostic mammogram. It’s often used to look closely at both breasts. […] A breast MRI can make more-detailed pictures of the breast. Sometimes this method is used to look closely for any other areas of cancer in the affected breast. It also might be used to look for cancer in the other breast.
- #16 Current State of Breast Cancer Diagnosis, Treatment, and Theranosticshttps://pmc.ncbi.nlm.nih.gov/articles/PMC8156889/
Breast MRI is a non-invasive and non-ionizing diagnostic imaging tool that employs low-energy radio frequency waves and a magnetic field to obtain detailed images of structures within the breast. MRI can be used to measure the size of the cancer and look for metastasized tumors in women who have been previously diagnosed with breast cancer. […] Dynamic contrast-agent-enhanced breast MRI works by analyzing the temporal enhancement pattern of a tissue following the intravenous injection of a paramagnetic contrast agent. This non-invasive imaging technique quantitatively determines the extent of tissue vascularization, interstitial space composition, and differentiation of lesions. […] Sentinel lymph node biopsy (SLNB) is a revolutionary, minimally-invasive method to determine whether metastasis has occurred in early-stage breast cancer patients.
- #17 ACS Breast Cancer Screening Guidelines | American Cancer Societyhttps://www.cancer.org/cancer/types/breast-cancer/screening-tests-and-early-detection/american-cancer-society-recommendations-for-the-early-detection-of-breast-cancer.html
Clinical breast exams (physical exams done by a health professional) are not recommended for breast cancer screening among average-risk women at any age. […] Regular mammograms can help find breast cancer at an early stage, when treatment is most likely to be successful. A mammogram can often find breast changes that could be cancer years before physical symptoms develop. […] Results from many decades of research clearly show that women who have regular mammograms are more likely to have breast cancer found earlier, are less likely to need aggressive treatments like surgery to remove the entire breast (mastectomy) and chemotherapy, and are more likely to be cured. […] The American Cancer Society recommends against MRI screening for women whose lifetime risk of breast cancer is less than 15%.
- #18 ACS Breast Cancer Screening Guidelines | American Cancer Societyhttps://www.cancer.org/cancer/types/breast-cancer/screening-tests-and-early-detection/american-cancer-society-recommendations-for-the-early-detection-of-breast-cancer.html
If MRI is used, it should be in addition to, not instead of, a screening mammogram. This is because although an MRI is more likely to find cancer than a mammogram, it may still miss some cancers that a mammogram would find. […] Most women at high risk should begin screening with MRI and mammograms when they are 30 and continue for as long as they are in good health.
- #19 Current State of Breast Cancer Diagnosis, Treatment, and Theranosticshttps://pmc.ncbi.nlm.nih.gov/articles/PMC8156889/
Breast MRI is a non-invasive and non-ionizing diagnostic imaging tool that employs low-energy radio frequency waves and a magnetic field to obtain detailed images of structures within the breast. MRI can be used to measure the size of the cancer and look for metastasized tumors in women who have been previously diagnosed with breast cancer. […] Dynamic contrast-agent-enhanced breast MRI works by analyzing the temporal enhancement pattern of a tissue following the intravenous injection of a paramagnetic contrast agent. This non-invasive imaging technique quantitatively determines the extent of tissue vascularization, interstitial space composition, and differentiation of lesions. […] Sentinel lymph node biopsy (SLNB) is a revolutionary, minimally-invasive method to determine whether metastasis has occurred in early-stage breast cancer patients.
- #20 Current State of Breast Cancer Diagnosis, Treatment, and Theranosticshttps://pmc.ncbi.nlm.nih.gov/articles/PMC8156889/
Breast specific gamma imaging (BSGI), a molecular breast imaging approach, is a specialized nuclear medicine imaging test that allows detection of sub-centimeter and mammographically occult breast cancer with a sensitivity and specificity comparable to MRI. […] Although mammography is a gold standard for breast cancer imaging, because of its limitations regarding dense breasts, another supplementing screening tool is required. Ultrasound is a supplemental tool that may be utilized to analyze some breast changes in women with dense breast tissues, as well as suspicious areas not seen on a mammogram. […] Breast cancer diagnosis by breast examination, mammography, breast ultrasound, MRI, and other imaging modalities can help identify tumors and other abnormalities in the tissue, as described above. These imaging modalities can help find a lump, an area of microcalcification, a suspicious area on ultrasound, or a gadolinium-enhanced area on MRI. Once breast cancer is identified using one of the diagnostic modalities discussed above, immediate and rigorous treatment must be provided to remove the tumor and prevent further spread of the cancer.
- #21 Diagnosis of breast cancer | Canadian Cancer Societyhttps://cancer.ca/en/cancer-information/cancer-types/breast/diagnosis
An x-ray uses small doses of radiation to make an image of parts of the body on film. It is used to find out if breast cancer has spread to the lungs. […] A bone scan is done if a woman has bone pain or the level of alkaline phosphatase is higher than normal. Doctors may also order a bone scan if a breast tumour is larger than 5 cm or they can feel lymph nodes under the arm (called axillary lymph nodes). […] An MRI is not used routinely to diagnose breast cancer. Doctors may use an MRI to better examine an abnormality found on mammography if they cant find it with other tests or if results from other tests are not clear. […] Ductography is a special type of x-ray that looks at the breast ducts. It is sometimes used to find out what is causing nipple discharge. It is also used to help diagnose an intraductal papilloma, which is a non-cancerous tumour that can cause nipple discharge.
- #22 Breast Cancer Workup: Approach Considerations, Breast Cancer Screening, Ultrasonographyhttps://emedicine.medscape.com/article/1947145-workup
Advances in mammography include the development of digital mammography and the increased use of computer-aided diagnosis (CAD) systems. CAD systems have been developed to help the radiologist identify mammographic abnormalities. Tomosynthesis mammography is a method of creating a three-dimensional image of the breast from x-ray cross-sections. Mammography with tomosynthesis increases cancer detection rates in asymptomatic patients. […] The US Preventive Services Task Force (USPSTF) reports that reduction in breast cancer mortality due to screening mammography varies with patient age. With screening mammography, relative risk (RR) of breast cancer mortality was 0.92 for women aged 39 to 49 years, 0.86 for those aged 50 to 59 years, 0.67 for those aged 60 to 69 years, and 0.80 for those aged 70 to 74 years. Risk of advanced breast cancer was reduced for women aged 50 years or older (RR 0.62) but not those aged 39 to 49 years (RR 0.98).
- #23 Breast Cancer Early Detection and Diagnosis | How To Detect Breast Cancer | American Cancer Societyhttps://www.cancer.org/cancer/types/breast-cancer/screening-tests-and-early-detection.html
Breast cancer is sometimes found after symptoms appear, but many women with breast cancer have no symptoms. This is why regular breast cancer screening is so important. […] Different tests can be used to look for and diagnose breast cancer. If your doctor finds an area of concern on a screening test (a mammogram), or if you have symptoms that could mean breast cancer, you will need more tests to know for sure if its cancer. […] A biopsy is done when mammograms, other imaging tests, or a physical exam shows a breast change that may be cancer. A biopsy is the only way to know for sure if its cancer.
- #24 Diagnosis of breast cancer | Canadian Cancer Societyhttps://cancer.ca/en/cancer-information/cancer-types/breast/diagnosis
Diagnosis is the process of finding out the cause of a health problem. Diagnosing breast cancer usually begins when you find a lump in your breast or a screening mammography suggests a problem with the breast. Your doctor will ask you about any symptoms you have and do a physical exam. Based on this information, your doctor may refer you to a specialist or order tests to check for breast cancer or other health problems. […] The following tests are usually used to rule out or diagnose breast cancer. Many of the same tests used to diagnose cancer are used to find out the stage (how far the cancer has progressed). Your doctor may also order other tests to check your general health and to help plan your treatment. […] A biopsy is the only definite way to diagnose breast cancer. During a biopsy, the doctor removes tissues or cells from the body so they can be tested in a lab. A report from the pathologist will confirm whether or not cancer cells are found in the sample.
- #25 Breast Cancer Diagnosis and Screening | AAFPhttps://www.aafp.org/pubs/afp/issues/2000/0801/p596.html
The current ACS screening guidelines for detection of breast cancer in asymptomatic women with no increased risk factors are shown in Table 5. […] Ultrasonographic screening is useful to differentiate between solid and cystic breast masses when a palpable mass is not well seen on a mammogram. […] The three breast biopsy techniques in current use are applicable to different diagnostic situations. Fine-needle aspiration (FNA) biopsy generally uses a 20-gauge needle to obtain samples from a solid mass for cytology. […] A clinically suspicious mass should be followed even if mammographic findings are normal. Lumpectomy should be done for suspicious masses and should include a 1-cm margin of normal tissue. FNA biopsy may be used as the initial diagnostic test. […] A patient with bilateral, milky nipple discharge should be evaluated for prolactinoma. Cytology of the discharge is rarely helpful. A mammogram should be obtained for a suspicious discharge even though results are usually negative.
- #26 Breast Cancer Diagnosis | Susan G. Komen®https://www.komen.org/breast-cancer/diagnosis/
If youve had an abnormal finding on a screening mammogram or youve noticed a change in your breast, youll have follow-up tests. These tests may ruleout breast cancer. If not, youll have a breast biopsy. A biopsy is the only test that can diagnose breast cancer. Most of the time, findings from a biopsy dont turn out to be breast cancer. […] If your biopsy shows breast cancer, learning about your breast cancer diagnosis will help you understand your treatment options. […] A biopsy is a test that removes a sample of cells or tissue from the suspicious area of your breast. The sample is studied under a microscope to see if cancer is present. […] Acore needle biopsyis the standard and preferred way to diagnose breast cancer. It involves removing samples of breast tissue from the suspicious area using a needle.
- #27 Breast Cancer Diagnosis, Tests and Early Detectionhttps://www.cancercenter.com/cancer-types/breast-cancer/diagnosis-and-detection
Some common biopsies used to help doctors diagnose breast cancer include fine-needle aspiration biopsy, which uses a small needle; core needle biopsy, which uses a larger needle; MRI-guided biopsy; or surgical biopsy, in which all or part of a lump is removed and checked for cancer. […] A sentinel lymph node biopsy may first be performed to determine whether cancer has spread to the lymph glands under the arm. […] In some cases, certain types of lab tests, called genomic tests, are used to learn more about the genetic makeup of breast cancer cells. Genomic tests can help the care team examine specific genes and proteins in the cancer cells and develop a treatment plan that is specifically geared to disrupt and fight the specific cancer. […] The Oncotype DX test (also called the 21-gene test) is used to determine whether breast cancer chemotherapy is likely to benefit women with early-stage breast cancer. This lab test also helps the cancer care team to know the likelihood of disease recurrence.
- #28 Tests for breast cancer | Cancer Research UKhttps://www.cancerresearchuk.org/about-cancer/breast-cancer/getting-diagnosed/tests
You usually have a number of tests to check for breast cancer. These include: a breast examination, mammogram, taking a sample of tissue from your breast called a biopsy, scans. […] Your GP might also ask about your family history. If you have a strong family history of cancer, there might be a faulty gene in your family that increases your risk of breast cancer. […] Some women do not have any symptoms and are referred to a breast clinic for tests if their screening mammogram shows an abnormal area. […] The tests you have can diagnose breast cancer and other breast conditions. […] A breast biopsy means taking samples of tissue from a suspicious area. It is the only way to find out if you have breast cancer or another breast condition. […] The tests can: diagnose breast cancer, show which type of breast cancer you have, look for proteins on the surface of the breast cancer cells.
- #29 Breast Cancer Diagnosis, Tests and Early Detectionhttps://www.cancercenter.com/cancer-types/breast-cancer/diagnosis-and-detection
Some common biopsies used to help doctors diagnose breast cancer include fine-needle aspiration biopsy, which uses a small needle; core needle biopsy, which uses a larger needle; MRI-guided biopsy; or surgical biopsy, in which all or part of a lump is removed and checked for cancer. […] A sentinel lymph node biopsy may first be performed to determine whether cancer has spread to the lymph glands under the arm. […] In some cases, certain types of lab tests, called genomic tests, are used to learn more about the genetic makeup of breast cancer cells. Genomic tests can help the care team examine specific genes and proteins in the cancer cells and develop a treatment plan that is specifically geared to disrupt and fight the specific cancer. […] The Oncotype DX test (also called the 21-gene test) is used to determine whether breast cancer chemotherapy is likely to benefit women with early-stage breast cancer. This lab test also helps the cancer care team to know the likelihood of disease recurrence.
- #30 Breast Cancer Diagnosis | Stanford Health Carehttps://stanfordhealthcare.org/medical-conditions/cancer/breast-cancer/patient-care-resources/diagnosis.html
If your mammogram or other screening tests show an abnormality, you may need a breast biopsy. This procedure takes a tiny sample of cells from the abnormal breast tissue. […] To obtain the most precise understanding of your cancer, your doctor may schedule different types of breast imaging to diagnose breast cancer. […] Genetic testing identifies mutations, or changes, in genes or chromosomes that increase your risk of developing cancer. For breast cancer, genetic testing can show whether you have inherited mutations in genes related to the disease, like BRCA1 or BRCA2. […] Our comprehensive risk assessment can help when breast cancer appears to run in your family. Given that 5-10% of breast cancers likely have hereditary causes, we offer additional steps to protect your health or adjust your treatment.
- #31 Current State of Breast Cancer Diagnosis, Treatment, and Theranosticshttps://pmc.ncbi.nlm.nih.gov/articles/PMC8156889/
Breast MRI is a non-invasive and non-ionizing diagnostic imaging tool that employs low-energy radio frequency waves and a magnetic field to obtain detailed images of structures within the breast. MRI can be used to measure the size of the cancer and look for metastasized tumors in women who have been previously diagnosed with breast cancer. […] Dynamic contrast-agent-enhanced breast MRI works by analyzing the temporal enhancement pattern of a tissue following the intravenous injection of a paramagnetic contrast agent. This non-invasive imaging technique quantitatively determines the extent of tissue vascularization, interstitial space composition, and differentiation of lesions. […] Sentinel lymph node biopsy (SLNB) is a revolutionary, minimally-invasive method to determine whether metastasis has occurred in early-stage breast cancer patients.
- #32 What to Expect When Diagnosed with Breast Cancer – Breast Cancer | UCLA Health Jonsson Comprehensive Cancer Centerhttps://www.uclahealth.org/cancer/cancer-services/breast-cancer/patient-resources/what-expect-when-diagnosed-with-breast-cancer
Breast cancer. It’s the diagnosis virtually all women fear, and understandably so. Breast cancer strikes one of every eight women in this country and almost everyone knows someone who has been diagnosed with this disease. […] However, with early diagnosis and advances in treatment, breast cancer can be treated successfully and, in many cases, cured. […] During the lumpectomy or mastectomy, some of the lymph nodes in the armpit will likely be removed to determine if the cancer has spread (lymph nodes in the underarm are the first place breast cancer spreads). […] For early breast cancers, sentinel lymph node biopsy is a technique in which the lymph nodes that first drain the breast are identified and sampled. If cancer is not found in the „sentinel” nodes, no additional lymph nodes need to be removed. This has the advantage of faster recovery and less risk of lymphedema (swelling of the arm).
- #33 Diagnosis of breast cancer | Canadian Cancer Societyhttps://cancer.ca/en/cancer-information/cancer-types/breast/diagnosis
Hormone receptor status testing looks for estrogen receptors (ERs) and progesterone receptors (PRs) in the breast cancer cells. This information will help your healthcare team decide which treatments will work best for you. […] HER2 status testing is done to find out if breast cancer cells are making more HER2 protein than normal (called overexpression). This information will help your healthcare team decide which treatments will work best for you. […] A CBC is done to check your general health. Your healthcare team also uses a CBC as a baseline that they can check against future blood counts taken during and after treatment. […] Blood chemistry tests measure certain chemicals in the blood. They show how well certain organs are functioning and can help find abnormalities. […] Tumour markers are substances found in the blood, tissues or fluids removed from the body.
- #34 How We Diagnose Breast Cancer | Dana-Farber Cancer Institutehttps://www.dana-farber.org/cancer-care/types/breast-cancer/diagnosis
Once a biopsy is completed, tissue samples are examined by pathologists who specialize exclusively in breast cancer. […] Researchers at Dana-Farber Brigham Cancer Center and elsewhere have discovered that breast cancers differ not only in their size, location, and behavior, but also in their genetic and hormonal characteristics. […] Cancer is staged based on tumor size, location, and the degree to which the cancer has spread, either to the lymph nodes and/or to other parts of the body. […] At Dana-Farber Brigham Cancer Center, breast pathologists collaborate closely with other members of your team to evaluate breast tissue and determine your tumor’s specific characteristics. […] The ability to distinguish between different subtypes of breast cancer has led to more refined treatments, allowing doctors to prescribe treatment likely to provide benefit, and reduce the use of therapies that may not be as effective an important consideration for patients’ quality of life.
- #35 Diagnosis of breast cancer | Canadian Cancer Societyhttps://cancer.ca/en/cancer-information/cancer-types/breast/diagnosis
Hormone receptor status testing looks for estrogen receptors (ERs) and progesterone receptors (PRs) in the breast cancer cells. This information will help your healthcare team decide which treatments will work best for you. […] HER2 status testing is done to find out if breast cancer cells are making more HER2 protein than normal (called overexpression). This information will help your healthcare team decide which treatments will work best for you. […] A CBC is done to check your general health. Your healthcare team also uses a CBC as a baseline that they can check against future blood counts taken during and after treatment. […] Blood chemistry tests measure certain chemicals in the blood. They show how well certain organs are functioning and can help find abnormalities. […] Tumour markers are substances found in the blood, tissues or fluids removed from the body.
- #36 Patient education: Breast cancer guide to diagnosis and treatment (Beyond the Basics) – UpToDatehttps://www.uptodate.com/contents/breast-cancer-guide-to-diagnosis-and-treatment-beyond-the-basics
The „stage” of the cancer is an indication of whether and how far it has spread. […] Women with stage I or II breast cancers are said to have „early-stage” localized breast cancer. […] Stage IV breast cancer refers to tumors that have metastasized to areas outside the breast and lymph nodes to the bones, lungs, liver, or other organs. […] The treatment of breast cancer must be individualized and is based upon several factors. […] Systemic therapy is recommended for the vast majority of women with stage II breast cancer, and for many women with stage I disease. […] The decision to treat early-stage breast cancer with chemotherapy is based on many factors, such as the stage and grade of a tumor and whether it lacks hormone receptors or makes a lot of the HER2 protein. […] The choice of treatment for metastatic breast cancer depends upon many individual factors, including features of the cancer (especially whether it produces hormone receptors and HER2), the expected response to various therapies, treatment-related side effects, the extent and location of metastases, and a woman’s personal preferences.
- #37 Diagnosis of breast cancer | Canadian Cancer Societyhttps://cancer.ca/en/cancer-information/cancer-types/breast/diagnosis
Hormone receptor status testing looks for estrogen receptors (ERs) and progesterone receptors (PRs) in the breast cancer cells. This information will help your healthcare team decide which treatments will work best for you. […] HER2 status testing is done to find out if breast cancer cells are making more HER2 protein than normal (called overexpression). This information will help your healthcare team decide which treatments will work best for you. […] A CBC is done to check your general health. Your healthcare team also uses a CBC as a baseline that they can check against future blood counts taken during and after treatment. […] Blood chemistry tests measure certain chemicals in the blood. They show how well certain organs are functioning and can help find abnormalities. […] Tumour markers are substances found in the blood, tissues or fluids removed from the body.
- #38 How We Diagnose Breast Cancer | Dana-Farber Cancer Institutehttps://www.dana-farber.org/cancer-care/types/breast-cancer/diagnosis
Estrogen and progesterone are both hormones. […] The HER2 protein can be present in excess amounts on the surface of the cancer cell. […] Approximately 15 percent of breast cancers do not express estrogen receptor, progesterone receptor, or HER2. […] Our diagnostic team provides second opinions, including for challenging or difficult cases.
- #39 Current State of Breast Cancer Diagnosis, Treatment, and Theranosticshttps://pmc.ncbi.nlm.nih.gov/articles/PMC8156889/
Triple-negative breast cancer (TNBC) accounts for about 10-15% of all breast cancers. In TNBC, the cancer cells do not possess estrogen or progesterone receptors and also do not produce too much of the protein HER2. […] It is clear from the above research that breast cancer nanotheranostics is a rapidly growing area that holds great promise as a method of combining cutting-edge technologies within a single platform to deliver breast cancer therapies in a targeted, sustained, and effective manner.
- #40 Breast Cancer Diagnosis: The Tests You May Gethttps://www.everydayhealth.com/breast-cancer/diagnosis-and-treatment.aspx
If you test negative for both hormone receptors and for HER2, your breast cancer is considered triple negative. […] If a doctor thinks there’s a chance you may have breast cancer, there are many different tests they may recommend. […] The most common test for diagnosing cancer is a biopsy, which takes a sample of tissue for analysis. […] If a biopsy is positive, doctors will likely request further testing to confirm the presence and type of cancer.
- #41 Breast Cancer Diagnosis, Tests and Early Detectionhttps://www.cancercenter.com/cancer-types/breast-cancer/diagnosis-and-detection
Some common biopsies used to help doctors diagnose breast cancer include fine-needle aspiration biopsy, which uses a small needle; core needle biopsy, which uses a larger needle; MRI-guided biopsy; or surgical biopsy, in which all or part of a lump is removed and checked for cancer. […] A sentinel lymph node biopsy may first be performed to determine whether cancer has spread to the lymph glands under the arm. […] In some cases, certain types of lab tests, called genomic tests, are used to learn more about the genetic makeup of breast cancer cells. Genomic tests can help the care team examine specific genes and proteins in the cancer cells and develop a treatment plan that is specifically geared to disrupt and fight the specific cancer. […] The Oncotype DX test (also called the 21-gene test) is used to determine whether breast cancer chemotherapy is likely to benefit women with early-stage breast cancer. This lab test also helps the cancer care team to know the likelihood of disease recurrence.
- #42 Breast Cancer Diagnosis | Stanford Health Carehttps://stanfordhealthcare.org/medical-conditions/cancer/breast-cancer/patient-care-resources/diagnosis.html
If your mammogram or other screening tests show an abnormality, you may need a breast biopsy. This procedure takes a tiny sample of cells from the abnormal breast tissue. […] To obtain the most precise understanding of your cancer, your doctor may schedule different types of breast imaging to diagnose breast cancer. […] Genetic testing identifies mutations, or changes, in genes or chromosomes that increase your risk of developing cancer. For breast cancer, genetic testing can show whether you have inherited mutations in genes related to the disease, like BRCA1 or BRCA2. […] Our comprehensive risk assessment can help when breast cancer appears to run in your family. Given that 5-10% of breast cancers likely have hereditary causes, we offer additional steps to protect your health or adjust your treatment.
- #43 Breast Cancer Diagnosis | NYU Langone Healthhttps://nyulangone.org/conditions/breast-cancer/diagnosis
Breast Cancer Diagnosis […] The diagnosis of breast cancer can be a very difficult time, and we are here to help you. […] If an abnormal growth is found during screening for breast cancer, doctors at NYU Langones Perlmutter Cancer Center use diagnostic imaging and sophisticated molecular tests to determine whether cancer is present and, if so, the type of breast cancer. This information helps doctors develop a customized treatment plan for you. […] The imaging tests used for breast cancer screening, including traditional and three-dimensional mammograms, ultrasound, and MRI, may also be used during diagnosis. If doctors identify a suspicious growth, they may recommend that a woman have a biopsy, the removal of breast tissue, so it can be examined for signs of cancer. […] After any type of biopsy, our pathologists examine tumor tissue under a microscope to determine if breast cancer is present and, if so, the type. They can also evaluate the lymph nodes to see if the cancer has spread beyond the breast. […] Pathologists test tumor tissue for hormonal and genetic features that can help guide treatment decisions. […] The female hormones estrogen and progesterone can contribute to the growth of breast cancer. In some women, breast cancer cells have receptors, or proteins, on their surface that attach to estrogen, progesterone, or both. Breast cancers that test positive for these receptors rely on these hormones to grow. […] Pathologists can also determine whether a tumor is positive for HER2, a protein that encourages cells to grow. […] If pathologists find that the tumor tissue is not positive for estrogen receptors, progesterone receptors, or HER2, the cancer is referred to as triple negative. […] Ki-67 is a marker of cell proliferation, which means that it can be used to measure the growth level of cancer cells. […] Perlmutter Cancer Center doctors can evaluate the presence and activity of proteins, hormone receptors, and genes, such as HER2, that are involved in the initiation, growth, proliferation, and spread of breast cancer cells.
- #44 Breast cancer – Diagnosis and treatment – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/breast-cancer/diagnosis-treatment/drc-20352475
A biopsy is a procedure to remove a sample of tissue for testing in a lab. […] The tissue sample from a biopsy goes to a lab for testing. Tests can show whether the cells in the sample are cancerous. Other tests give information about the type of cancer and how quickly it’s growing. […] Once your healthcare team diagnoses your breast cancer, you may have other tests to figure out the extent of the cancer. This is called the cancer’s stage. Your healthcare team uses your cancer’s stage to understand your prognosis. […] Tests and procedures used to stage breast cancer may include: Blood tests, such as a complete blood count and tests to show how well the kidneys and liver are working. Bone scan. CT scan. MRI. Positron emission tomography scan, also called a PET scan. […] Breast cancer stages range from 0 to 4. A lower number means the cancer is less advanced and more likely to be cured. Stage 0 breast cancer is cancer that is contained within a breast duct. It hasn’t broken out to invade the breast tissue yet. As the cancer grows into the breast tissue and gets more advanced, the stages get higher. A stage 4 breast cancer means that the cancer has spread to other parts of the body.
- #45 Patient education: Breast cancer guide to diagnosis and treatment (Beyond the Basics) – UpToDatehttps://www.uptodate.com/contents/breast-cancer-guide-to-diagnosis-and-treatment-beyond-the-basics
To evaluate a breast lump, a mammogram and a breast ultrasound are usually recommended. If suspicious, a breast biopsy may also be recommended. […] A mammogram is a very low-dose X-ray of the breast. […] Mammograms are currently the best screening method to detect breast cancer. […] Breast MRI is not usually used to screen for breast cancer but can aid in the diagnosis of breast cancer in select situations. […] If breast cancer is suspected, the next step is to sample the abnormal area to confirm the diagnosis. […] The presence or absence of lymph node involvement is one of the most important factors in determining the long-term outcome of the cancer (prognosis), and it often guides decisions about treatment. […] The axillary lymph nodes should be examined for tumor spread. […] Oncologists (doctors who care for people with cancer) use a standard set of abbreviations, called the TNM staging system, to describe the stage of individual cancers.
- #46 Diagnosis of breast cancer | Canadian Cancer Societyhttps://cancer.ca/en/cancer-information/cancer-types/breast/diagnosis
An x-ray uses small doses of radiation to make an image of parts of the body on film. It is used to find out if breast cancer has spread to the lungs. […] A bone scan is done if a woman has bone pain or the level of alkaline phosphatase is higher than normal. Doctors may also order a bone scan if a breast tumour is larger than 5 cm or they can feel lymph nodes under the arm (called axillary lymph nodes). […] An MRI is not used routinely to diagnose breast cancer. Doctors may use an MRI to better examine an abnormality found on mammography if they cant find it with other tests or if results from other tests are not clear. […] Ductography is a special type of x-ray that looks at the breast ducts. It is sometimes used to find out what is causing nipple discharge. It is also used to help diagnose an intraductal papilloma, which is a non-cancerous tumour that can cause nipple discharge.
- #47 Breast Cancer Diagnosis, Tests and Early Detectionhttps://www.cancercenter.com/cancer-types/breast-cancer/diagnosis-and-detection
Interventional radiologists physicians who specialize in minimally invasive, targeted treatments use specific imaging and radio wave tests to detect metastasis in various parts of the body. […] The care team may perform a bone scan to reveal whether breast cancer has spread to the bone. By capturing images of bones on a computer, bone scans may reveal important information, such as the location of the bone metastasis.
- #48 Patient education: Breast cancer guide to diagnosis and treatment (Beyond the Basics) – UpToDatehttps://www.uptodate.com/contents/breast-cancer-guide-to-diagnosis-and-treatment-beyond-the-basics
To evaluate a breast lump, a mammogram and a breast ultrasound are usually recommended. If suspicious, a breast biopsy may also be recommended. […] A mammogram is a very low-dose X-ray of the breast. […] Mammograms are currently the best screening method to detect breast cancer. […] Breast MRI is not usually used to screen for breast cancer but can aid in the diagnosis of breast cancer in select situations. […] If breast cancer is suspected, the next step is to sample the abnormal area to confirm the diagnosis. […] The presence or absence of lymph node involvement is one of the most important factors in determining the long-term outcome of the cancer (prognosis), and it often guides decisions about treatment. […] The axillary lymph nodes should be examined for tumor spread. […] Oncologists (doctors who care for people with cancer) use a standard set of abbreviations, called the TNM staging system, to describe the stage of individual cancers.
- #49 Diagnosis and Stages of Breast Cancer – Brigham and Women’s Hospitalhttps://www.brighamandwomens.org/surgery/breast-surgery/breast-cancer-diagnosis-and-stages
If an imaging test reveals an abnormal finding that cannot be resolved through other imaging techniques, your doctor will likely recommend a biopsy. A biopsy involves the removal of a small sample of tissue through one of several techniques, depending on the location and quality of the tissue to be examined. […] Once a biopsy is completed, tissue samples are examined by pathologists who specialize exclusively in breast cancer. Pathologists’ findings are critical to determining the best treatment for your cancer. […] After receiving a diagnosis of breast cancer, our team will try to determine your stage of cancer. The stage of cancer is based on the tumor size, location and degree to which the cancer has spread in your body to lymph nodes and/or other parts of your body. It is one of the most important things to know when deciding how to best treat your cancer, including whether your cancer can be removed (resected) with surgery. […] The AJCC (American Joint Committee on Cancer) TNM staging system (Stages 0IV) is commonly used for breast cancer. The AJCC staging system for breast cancer now includes details about breast cancer biology in its staging.
- #50 Breast Cancer: Symptoms, Types, Causes & Treatmenthttps://my.clevelandclinic.org/health/diseases/3986-breast-cancer
Breast cancer is one of the most common cancers that affects women. It happens when cancerous cells in your breasts multiply and become tumors. About 80% of breast cancer cases are invasive, meaning a tumor may spread from your breast to other areas of your body. […] Healthcare providers may do physical examinations or order mammograms to check for signs of breast cancer. But they do the following tests to diagnose the disease: Breast ultrasound, Breast magnetic resonance imaging (MRI) scan, Breast biopsy, Immunohistochemistry test to check for hormone receptors, Genetic tests to identify mutations that cause breast cancer. […] Healthcare providers use cancer staging systems to plan treatment. Staging cancer also helps providers set a prognosis, or what you can expect after treatment. Breast cancer staging depends on factors like breast cancer type, tumor size and location, and whether cancer has spread to other areas of your body. Breast cancer stages are: Stage 0: The disease is noninvasive, meaning it hasnt spread from your breast ducts to other parts of your breast. Stage I: There are cancerous cells in nearby breast tissue. Stage II: The cancerous cells have formed a tumor or tumors. The tumor is either smaller than 2 centimeters across and has spread to underarm lymph nodes or larger than 5 centimeters across but hasnt spread to underarm lymph nodes. Tumors at this stage can measure anywhere between 2 and 5 centimeters across, and may or may not affect the nearby lymph nodes. Stage III: Theres breast cancer in nearby tissue and lymph nodes. Stage III is usually referred to as locally advanced breast cancer. Stage IV: Cancer has spread from your breast to areas like your bones, liver, lungs or brain. […] The most significant complication is metastatic breast cancer breast cancer that spreads to other areas of your body, including your brain, bones, liver and lungs. Studies show about 1 in 3 women who have early-stage cancer later develop metastatic breast cancer.
- #51 Breast Cancer Diagnosis, Types & Stages | Memorial Sloan Kettering Cancer Centerhttps://www.mskcc.org/cancer-conditions/breast-cancer/diagnosis
There are 5 stages of breast cancer, from 0 to 4 (0 to IV). The lower the number, the less the cancer has spread. […] Knowing the stage of the cancer helps you and your doctor decide on the best treatment options for you. […] Stage 0 describes noninvasive breast cancers or precancers. This includes ductal carcinoma in situ (DCIS), the most common form of noninvasive cancer. […] Stage 1 describes a very early stage of invasive cancer. At this point, tumor cells have spread to healthy nearby breast tissue. […] Stage 2 is cancer thats in a small area of the breast, but has grown larger. It may also involve lymph nodes. […] Stage 3: Cancer has spread further into the breast and lymph nodes. […] Stage 4 is the most advanced stage. Breast cancer has spread to nearby lymph nodes and to distant areas beyond the breast. It may have spread to organs, such as the lungs, liver, or brain, or to the bones.
- #52 Breast Cancer Facts & Stats 2024 – Incidence, Age, Survival, & Morehttps://www.nationalbreastcancer.org/breast-cancer-facts/
1 in 8 women in the United States will be diagnosed with breast cancer in her lifetime. […] To determine the extent of an individualâs breast cancer and if it has spread outside of the breast, the cancer is assigned a stage upon diagnosis. The early detection of breast cancer through annual mammography and other breast exams is the best defense against receiving a late-stage breast cancer diagnosis. Generally speaking, the earlier the cancer is detected, the greater the likelihood of a successful outcome. […] Approximately 66% of breast cancer cases are diagnosed at a localized stage, before cancer has spread outside of the breast, when it is easiest to treat. […] The 5-year relative survival rate for cancer diagnosed at the localized stage is 99%. […] Women who receive regular screenings for breast cancer have a 26% lower breast cancer death rate than women who do not receive screenings.
- #53 Breast Cancer – Women’s Health Issues – Merck Manual Consumer Versionhttps://www.merckmanuals.com/home/women-s-health-issues/breast-cancer/breast-cancer
The number and location of lymph nodes that contain cancer cells is one of the main factors that determine whether the cancer can be cured and, if not, how long women will live. […] The 5-year survival rate for breast cancer (the percentage of women who are alive 5 years after diagnosis) is 99% if the cancer remains at its original site (localized).
- #54 AI Breast Cancer Detection and Diagnosis| Breast Cancer Research Foundationhttps://www.bcrf.org/blog/ai-breast-cancer-detection-screening/
When it comes to breast cancer, artificial Intelligence (AI) has already made headlines as a powerful tool for early and accurate breast cancer detectionan essential goal that improves outcomes and saves lives. […] Regular screeningmost commonly through mammographyis currently the most effective way to detect breast cancer early, when its more likely to be smaller and contained in the breast. […] Mammography has long been the gold standard for breast cancer screening and is highly effective in detecting abnormalities in breast tissue that could be cancer long before patients experience lumps and other symptoms. […] AI algorithms may make radiologists workflow far more efficient, and they can provide quantitative analyses that are not subject to human bias, making data-driven calls for questionable mammograms that could be interpreted differently.
- #55 AI Breast Cancer Detection and Diagnosis| Breast Cancer Research Foundationhttps://www.bcrf.org/blog/ai-breast-cancer-detection-screening/
AI techniques can help radiologists identify breast cancer that would have otherwise been undetectable in its early stages. […] AI-powered breast imaging may also improve breast cancer care in low-resourced or rural areas, where women often lack easy access to specialists and experts. […] BCRF investigators Drs. Constance Lehman and Regina Barzilay developed and tested a mammography-based deep learning model called MIRAI. […] BCRF investigator Dr. Adam Yala and Dr. Barzilay are now conducting a BCRF-supported prospective study testing MIRAIs ability to predict which patients are high-risk and follow their progress through MRI screening. […] In her current BCRF project, Dr. Lehman is leveraging MIRAI to move breast cancer screening protocols from an age-based paradigm to a risk-based one, which would particularly benefit high-risk young (under 40) women who arent generally being screened.
- #56 AI Breast Cancer Detection and Diagnosis| Breast Cancer Research Foundationhttps://www.bcrf.org/blog/ai-breast-cancer-detection-screening/
AI techniques can help radiologists identify breast cancer that would have otherwise been undetectable in its early stages. […] AI-powered breast imaging may also improve breast cancer care in low-resourced or rural areas, where women often lack easy access to specialists and experts. […] BCRF investigators Drs. Constance Lehman and Regina Barzilay developed and tested a mammography-based deep learning model called MIRAI. […] BCRF investigator Dr. Adam Yala and Dr. Barzilay are now conducting a BCRF-supported prospective study testing MIRAIs ability to predict which patients are high-risk and follow their progress through MRI screening. […] In her current BCRF project, Dr. Lehman is leveraging MIRAI to move breast cancer screening protocols from an age-based paradigm to a risk-based one, which would particularly benefit high-risk young (under 40) women who arent generally being screened.
- #57 AI Breast Cancer Detection and Diagnosis| Breast Cancer Research Foundationhttps://www.bcrf.org/blog/ai-breast-cancer-detection-screening/
If screening reveals a malignancy, timely and accurate diagnosis by breast tissue biopsy is critical to get a patient into treatment. […] Integrating AI into digital pathology is proving to be a revolutionary tool to improve imaging sensitivity and specificity and help pathologists work faster, while diagnosing breast cancers accurately. […] AI can identify subtle patterns and features in digitized pathology images that may be overlooked by human eyes. […] AI has improved MRI detection and characterization of breast cancer and will improve the use of imaging biomarkers in clinical decision-making. […] AI tools are enabling more accurate detection of these biomarkers, including low and ultra-low levels of HER2, so patients can get the right diagnosis and treatment. […] By harnessing the power of AI-driven analytics and automation, healthcare providers can deliver more precise, efficient, and tailored breast cancer care. […] Despite its transformative potential, there are challenges for AI on the road to widespread adoption in imaging.
- #58 Breast Cancer Diagnosticshttps://waltlab.bwh.harvard.edu/research/diagnostics/breast-cancer-diagnostics-2/
The Walt Lab is developing a blood test that can be combined with mammographic imaging to overcome the challenges with current screening methods and detect aggressive cancers early and accurately. The goal of this study is to determine if a blood test at the time of breast imaging could reduce the number of women who are recommended to have breast tissue biopsied, but do not have breast cancer (i.e., the biopsy is benign). Studying blood-based biomarkers could provide molecular information that will enable us to learn more about how breast cancers develop, and whether there are early changes that can predict who will develop breast cancer. The information we collect in this study will be used to better identify high risk individuals whose short-term risk of breast cancer is much higher, and enable better timing of risk-reducing interventions, such as medications or surgery.
- #59 ACS Breast Cancer Screening Guidelines | American Cancer Societyhttps://www.cancer.org/cancer/types/breast-cancer/screening-tests-and-early-detection/american-cancer-society-recommendations-for-the-early-detection-of-breast-cancer.html
Finding breast cancer early and getting state-of-the-art cancer treatment are two of the most important ways to prevent deaths from breast cancer. […] If breast cancer is found early, when its small and has not spread, it is easier to treat successfully. Getting regular screening tests is the most reliable way to find breast cancer early. […] The goal of screening tests for breast cancer is to find it early, before it causes symptoms (like a lump in the breast that can be felt). Early detection means finding and diagnosing a disease earlier than if youd waited for symptoms to start. […] Breast cancers found during screening exams are more likely to be smaller and less likely to have spread outside the breast. The size of a breast cancer and how far it has spread are some of the most important factors in predicting the prognosis (outlook) of a woman with this disease.
- #60 Breast Cancer Facts & Stats 2024 – Incidence, Age, Survival, & Morehttps://www.nationalbreastcancer.org/breast-cancer-facts/
1 in 8 women in the United States will be diagnosed with breast cancer in her lifetime. […] To determine the extent of an individualâs breast cancer and if it has spread outside of the breast, the cancer is assigned a stage upon diagnosis. The early detection of breast cancer through annual mammography and other breast exams is the best defense against receiving a late-stage breast cancer diagnosis. Generally speaking, the earlier the cancer is detected, the greater the likelihood of a successful outcome. […] Approximately 66% of breast cancer cases are diagnosed at a localized stage, before cancer has spread outside of the breast, when it is easiest to treat. […] The 5-year relative survival rate for cancer diagnosed at the localized stage is 99%. […] Women who receive regular screenings for breast cancer have a 26% lower breast cancer death rate than women who do not receive screenings.
- #61 Breast Cancer Facts & Stats 2024 – Incidence, Age, Survival, & Morehttps://www.nationalbreastcancer.org/breast-cancer-facts/
1 in 8 women in the United States will be diagnosed with breast cancer in her lifetime. […] To determine the extent of an individualâs breast cancer and if it has spread outside of the breast, the cancer is assigned a stage upon diagnosis. The early detection of breast cancer through annual mammography and other breast exams is the best defense against receiving a late-stage breast cancer diagnosis. Generally speaking, the earlier the cancer is detected, the greater the likelihood of a successful outcome. […] Approximately 66% of breast cancer cases are diagnosed at a localized stage, before cancer has spread outside of the breast, when it is easiest to treat. […] The 5-year relative survival rate for cancer diagnosed at the localized stage is 99%. […] Women who receive regular screenings for breast cancer have a 26% lower breast cancer death rate than women who do not receive screenings.